End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.64 CNY | +1.85% | +2.74% | -9.77% |
12/06 | Sansure Biotech's Tuberculosis Diagnostic Kit Gets EU Certification | MT |
26/04 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.77% | 135.54Cr | |
-6.61% | 1.21TCr | |
+94.64% | 819.97Cr | |
-22.14% | 658.64Cr | |
+9.29% | 588.57Cr | |
-21.66% | 347.09Cr | |
+5.12% | 252.41Cr | |
+42.27% | 247.9Cr | |
+14.95% | 230.26Cr | |
-18.96% | 157.6Cr |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Sansure Biotech Inc. announced that it has received $77 million in funding from Lilly Asia Ventures, HighLight Capital, Junhe Capital